Genentech and NVIDIA Join Forces for AI-Powered Drug Discovery
American biotechnology corporation Genentech, a key player in research and early drug development and a subsidiary of the Roche Group,
Read moreAmerican biotechnology corporation Genentech, a key player in research and early drug development and a subsidiary of the Roche Group,
Read moreMcMaster University and the Massachusetts Institute of Technology researchers using artificial intelligence (AI) have discovered a new type of antibiotic
Read moreMachine learning tissue classifiers are one of the most powerful and promising AI-based clinical research solutions for all types of
Read moreFrench pharma giant Sanofi and British pharmatech business Exscientia revealed a ground-breaking research cooperation and licensing agreement to develop up
Read moreGoogle’s parent company Alphabet Inc has announced the launch of a new UK-based company called Isomorphic Labs, dedicated to applying
Read moreNucleai and Merck KGaA will collaborate utilizing Nucleai’s AI-powered platform to develop pathology-based biomarkers as companion diagnostics. Nucleai, a precision
Read moreIQVIA™ has launched it’s Clinical Data Analytics Suite (CDAS), a new SaaS-based clinical data analytics platform that combines structured and
Read moreInsilico Medicine, a Hong Kong-based pioneering biotechnology company, specialising in end-to-end artificial intelligence for target discovery, small molecule chemistry, and
Read moreEngine Biosciences, a company deciphering complex biology to unleash impactful therapeutics plans to use funds from a $43 million funding
Read moreExscientia, a leading artificial intelligence (AI) driven pharmatech company based in Oxford, England, announced that the first AI-designed molecule for
Read more